![]() | |
Names | |
---|---|
Other names 5-phospho-alpha-D-ribose 1-diphosphate | |
Identifiers | |
3D model (JSmol) | |
ChEBI | |
ChemSpider | |
DrugBank | |
MeSH | Phosphoribosyl+pyrophosphate |
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C5H13O14P3 |
Molar mass | 390.07 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Phosphoribosyl pyrophosphate (PRPP) is a pentosephosphate.
It is formed from ribose 5-phosphate by the enzyme ribose-phosphate diphosphokinase.
It plays a role in transferring phospho-ribose groups in several reactions:
Enzyme | Reactant | Product |
---|---|---|
adenine phosphoribosyltransferase | adenine | AMP |
hypoxanthine-guanine phosphoribosyltransferase | guanine | GMP |
hypoxanthine-guanine phosphoribosyltransferase | hypoxanthine | IMP |
orotate phosphoribosyltransferase | orotate | OMP |
uracil phosphoribosyltransferase | uracil | UMP |
In de novo generation of purines, the enzyme amidophosphoribosyltransferase acts upon PRPP to create phosphoribosylamine.
Increased PRPP
Increased levels of PRPP is characterized by the overproduction and accumulation of uric acid leading to hyperuricemia and hyperuricosuria. It is one of the causes of gout.
Increased levels of PRPP are present in Lesch–Nyhan Syndrome. Decreased levels of hypoxanthine guanine phosphoribosyl transferase (HGPRT) causes this accumulation, as PRPP is a substrate used by HGPRT during purine salvage.
See also
- Pyrimidine biosynthesis